Assessing Better Bottles for Babies

NCT ID: NCT06357299

Last Updated: 2025-06-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

76 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-05-28

Study Completion Date

2026-05-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will use a 2 x 2 factorial design to test impact of two intervention strategies (bottle size and bottle opacity) on infant weight gain.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Infants who gain weight rapidly have over 4 times higher odds of developing obesity as a child or adult; infants who are predominantly bottle-fed are at higher risk for excessive infancy weight gain and childhood obesity, yet there are not effective interventions to reduce excessive weight gain among infants who are bottle-fed. The investigators' preliminary work suggest that two novel intervention strategies are feasible and may reduce excessive infancy weight gain: reducing bottle size; and increasing bottle opacity. The investigators aim to test the independent and joint efficacy of these two intervention components among exclusively bottle-fed infants in a randomized, full factorial clinical trial. The investigators' primary objective is to measure the change in conditional weight gain z-score (CWGz) from birth to four months by study group. 4 groups are composed of two conditions: smaller bottles and opaque bottles, independently and in combination, via a 2x2 factorial trial design.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pediatric Obesity Weight Gain Trajectory Infant Obesity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

FACTORIAL

2x2 factorial design
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Standard, Clear

This group will receive standard-sized clear bottles

Group Type EXPERIMENTAL

Standard Bottle Size

Intervention Type BEHAVIORAL

Standard sized bottle

Clear Bottle

Intervention Type BEHAVIORAL

Clear bottle

Standard, Opaque

This group will receive standard-sized opaque bottles

Group Type EXPERIMENTAL

Standard Bottle Size

Intervention Type BEHAVIORAL

Standard sized bottle

Opaque Bottle

Intervention Type BEHAVIORAL

Opaque bottle

Small, Clear

This group will receive small-sized clear bottles

Group Type EXPERIMENTAL

Small Bottle Size

Intervention Type BEHAVIORAL

Small sized bottle

Clear Bottle

Intervention Type BEHAVIORAL

Clear bottle

Small, Opaque

This group will receive small-sized opaque bottles

Group Type EXPERIMENTAL

Small Bottle Size

Intervention Type BEHAVIORAL

Small sized bottle

Opaque Bottle

Intervention Type BEHAVIORAL

Opaque bottle

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Small Bottle Size

Small sized bottle

Intervention Type BEHAVIORAL

Standard Bottle Size

Standard sized bottle

Intervention Type BEHAVIORAL

Clear Bottle

Clear bottle

Intervention Type BEHAVIORAL

Opaque Bottle

Opaque bottle

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Child is 3 days old to 1 month old
* Greater than 37 weeks gestational age at birth
* Birth weight greater than 3% for sex-specific WHO growth standard
* Caregiver must plan to use local clinic as infant's primary medical home for first 6 months of life
* Caregiver must speak English or Spanish as primary preferred language
* Caregiver age 18 years or older
* Caregiver must agree to use intervention bottles assigned during randomization and agree to stop using their existing bottles during the study period

Exclusion Criteria

* Multiple gestation
* Significant congenital anomaly or acquired or inherited condition directly affecting feeding, physiology, metabolism, or growth
* Feeding with soy-based, hydrolyzed, lactose-reduced, or elemental formula
* Weight loss greater than 95% for population reference in the first two weeks of life
Minimum Eligible Age

3 Days

Maximum Eligible Age

1 Month

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institutes of Health (NIH)

NIH

Sponsor Role collaborator

Duke University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Charles T Wood, MD, MPH

Role: PRINCIPAL_INVESTIGATOR

Duke University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Duke University

Durham, North Carolina, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Janna B Howard, MPH

Role: CONTACT

919-620-4793

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Janna Howard

Role: primary

919-620-4793

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Pro00115060

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Maternal and Infant Growth Study
NCT02893319 COMPLETED NA